Pandemic akin to war, lawyer tells Covid inquiry
Decisions were “finely balanced” and, with hindsight, might have been different, Fiona Scolding KC says.
Similar Posts
Supreme Court agrees to hear showdown over abortion pill access
Mifepristone, the first medication in a medical abortion, is prepared for a patient at Alamo Women’s Clinic in Carbondale, Illinois, April 20, 2023. Evelyn Hockstein | Reuters The Supreme Court on Wednesday took up a high-stakes legal battle that could lead to a definitive decision on whether the drug most commonly used for medication abortions…
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Covid inquiry: Bereaved daughters want lessons learned
Campaigners said they were not satisfied with Boris Johnson’s answers at the Covid inquiry.
Record 20 million Americans signed up for Affordable Care Act coverage for 2024
Twenty million Americans signed up for affordable health insurance for 2024, breaking an enrollment record under the Affordable Care Act for the third consecutive year, the Centers for Medicare & Medicaid Services announced Wednesday. “With six days left to still get covered, 8 million more Americans have signed up for ACA coverage than when I took office,”…
Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
